Zuzanna Julia Wojtczak (Sidoruk)

Mrs. Zuzanna Julia Wojtczak (Sidoruk)

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2025 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
MLMaksymilian Lewicki
Maksymilian Lewicki
Sylwia Górczyńska-KosiorzSylwia Górczyńska-Kosiorz
Sylwia Górczyńska-Kosiorz
PFPiotr Frydrychowski
Piotr Frydrychowski
Z(Zuzanna Julia Wojtczak (Sidoruk)
Zuzanna Julia Wojtczak (Sidoruk)
ANAgnieszka Noszczyk-Nowak
Agnieszka Noszczyk-Nowak
Myxomatous mitral valve disease (MMVD) is the most prevalent cardiac disorder in small and toy breed dogs, with the Cavalier King Charles Spaniel (CKCS) showing exceptionally high predisposition and early onset of the disease. MMVD is characterized by progressive mitral valve degeneration, volume overload, and eventual development of congestive heart failure (CHF). Given the strong hereditary component in CKCS, considerable research has focused on elucidating the genetic basis of MMVD in this breed. This review article summarizes the current state of knowledge on the phenotypic features, inheritance, and candidate loci potentially responsible for early onset and severe course of the disease. The pathogenesis of the disease, its classification, and the effects of breeding programs aimed at reducing the occurrence of MMVD have been described. Key findings include associations between MMVD severity and polymorphisms in genes such as NEBL, ACE, CDK6, HEPACAM2, COL5A1, and FAH, as well as evidence implicating dysregulated TGF-β signaling, serotonin signaling, and extracellular matrix remodeling pathways. The current state of knowledge on the role of miRNA in the pathogenesis of MMVD was also summarized. Despite these findings, no specific high-penetrating mutation has been identified. MMVD is a complex, polygenic condition shaped by regulatory variants and breed-specific genetic bottlenecks. Comparative studies underscore the translational relevance of canine MMVD to human mitral valve disease, while genomic insights may be basis for the future selective breeding strategies and therapeutic approaches. Further large-scale, integrative studies combining genomics, transcriptomics, and functional validation are needed to clarify disease mechanisms and support targeted treatment in CKCS as well as the development of new breeding strategies and programs.

10 April 2026 in Australian Veterinary Journal
Verified
Journal Article
Open access
PDF file
Z(Zuzanna Julia Wojtczak (Sidoruk)
Zuzanna Julia Wojtczak (Sidoruk)
MLM Lewicki
M Lewicki
MPM Płóciennik
M Płóciennik
JGJ Gach
J Gach
KNK Nowak
K Nowak
ANAgnieszka Noszczyk-Nowak
Agnieszka Noszczyk-Nowak
Reel Syndrome is a rare complication of permanent pacemaker implantation, characterised by the rotation of the device around its transverse axis, which causes the lead to coil around the generator and displacement, leading to pacing dysfunction. This report presents the first documented case of Reel Syndrome in a dog. The, 6‐year‐old female Labrador Retriever required a pacemaker implantation due to a diagnosed third‐degree atrioventricular block. Forty‐eight hours after pacemaker implantation, the dog developed clinical signs, including diaphragmatic contractions and a decrease in heart rate. Fluoroscopy confirmed the characteristic coiling of the lead around the generator, leading to a definitive diagnosis. Reel Syndrome can occur due to mechanical manipulation of the device by the patient, such as scratching or rubbing against objects as well as due to movement of the pacemaker system if it is not properly secured. Prevention involves securing the pacemaker and lead properly during implantation, ensuring close postoperative monitoring, and implementing protective measures such as an Elizabethan collar and pharmacological sedation to limit activity. Early diagnosis and intervention are crucial to prevent severe clinical consequences. This case highlights the importance of early recognition of Reel Syndrome and the need for proper stabilisation of the pacemaker and lead to prevent complications. Based on experience in human medicine, the described therapeutic approach may serve as a reference point for veterinary practice.

24 June 2026 in Animals
Verified
Journal Article
Open access
PDF file
MLMaksymilian Lewicki
Maksymilian Lewicki
Sylwia Górczyńska-KosiorzSylwia Górczyńska-Kosiorz
Sylwia Górczyńska-Kosiorz
JGJustyn Gach
Justyn Gach
PFPiotr Frydrychowski
Piotr Frydrychowski
Z(Zuzanna Julia Wojtczak (Sidoruk)
Zuzanna Julia Wojtczak (Sidoruk)
ANAgnieszka Noszczyk-Nowak
Agnieszka Noszczyk-Nowak
Myxomatous mitral valve disease (MMVD) is the most common acquired cardiac disease in small-breed dogs and shows particularly high prevalence and early onset in Cavalier King Charles Spaniels (CKCS). Although MMVD is considered a complex, polygenic disease, the clinical relevance of individual genetic variants remains incompletely understood. The angiotensin-converting enzyme (ACE) gene variant rs850683722 has previously been associated with altered ACE activity and differences in renin–angiotensin–aldosterone system-related responses in dogs with MMVD. The aim of this study was to determine the prevalence of rs850683722 in a Polish population of CKCS dogs and to assess whether this variant is associated with the clinical course of MMVD. A total of 105 CKCS dogs were included in the study. All dogs underwent standardized cardiovascular evaluation, including echocardiography, electrocardiography, and systolic blood pressure measurement. MMVD diagnosis and staging were performed according to current ACVIM consensus criteria. Genotyping of the rs850683722 variant was performed using Sanger sequencing for 95 dogs, while next-generation sequencing data was obtained for 10 dogs. Genotype distribution, allele frequencies, conformity with the Hardy–Weinberg equilibrium (HWE), sex-related differences, and associations between genotype and age at progression to selected MMVD stages or the primary clinical endpoint were assessed statistically. The most frequent genotype was AA, detected in fifty-nine dogs, followed by GG in thirty-seven dogs and AG in nine dogs. When dogs carrying at least one A allele were considered variant-positive, the overall prevalence of the variant-positive genotype was 64.8%. The calculated allele frequencies were 0.605 for the A allele and 0.395 for the G allele. The observed genotype distribution deviated markedly from the Hardy–Weinberg equilibrium, mainly because of a pronounced deficit of heterozygous dogs. No significant association was detected between genotype and sex. Genotype was also not significantly associated with age at progression to stage B2 or stage C. A statistically significant difference in age of death was demonstrated by genotype, but this difference was not reflected in the survival analysis. The rs850683722 variant was highly prevalent in the studied Polish CKCS population, with a frequency comparable to previously reported data for this breed. Despite its documented biological association with ACE activity and RAAS-related responses, the variant was not significantly associated with the clinical progression of MMVD in this cohort. These findings suggest that rs850683722 alone seems unlikely to be a reliable marker for predicting the severity or rate of MMVD progression in Polish CKCS dogs. Further studies including larger cohorts, longer follow-up, pedigree information, and the direct assessment of RAAS activity may help clarify whether this variant has stage-dependent or treatment-related clinical relevance.

15 February 2026 in Biology
Verified
Journal Article
Open access
PDF file
PFPiotr Frydrychowski
Piotr Frydrychowski
ACAlicja Cepiel-Kośmieja
Alicja Cepiel-Kośmieja
Z(Zuzanna Julia Wojtczak (Sidoruk)
Zuzanna Julia Wojtczak (Sidoruk)
KNKrzysztof Nowak
Krzysztof Nowak
ANAgnieszka Noszczyk-Nowak
Agnieszka Noszczyk-Nowak
Ventricular arrhythmias are among the most life-threatening cardiac rhythm disturbances. Owing to their complex pathophysiology and high mortality risk, they remain a major focus of research aimed at elucidating underlying mechanisms and improving prevention and therapeutic strategies. In this context, animal models—particularly large-animal models—are of pivotal importance because they more closely recapitulate human cardiac anatomy and electrophysiology. The most commonly used species include dogs, cats, pigs, sheep and goats. Dogs have historically played a prominent role in ventricular arrhythmia research; however, their use is increasingly constrained by legal regulations and ethical–societal considerations. Sheep and goats, although employed less frequently, have also contributed meaningfully to advances in the field. Among large-animal models, swine are regarded as especially promising, largely due to the similarity between porcine and human hearts and the feasibility of reliably inducing ventricular arrhythmias, particularly under conditions of acute ischemia associated with coronary artery occlusion. Large-animal models are also indispensable for the preclinical evaluation of novel drugs, therapeutic approaches, and medical devices prior to translation into human studies. In this article, we review selected investigations employing large-animal models of ventricular arrhythmias, with particular emphasis on the materials and methods reported in the cited literature.

13 July 2026 in Veterinary and Animal Science
Verified
Journal Article
Open access
MLMaksymilian Lewicki
Maksymilian Lewicki
SGSylwia Górczyńska-Kosiorz
Sylwia Górczyńska-Kosiorz
PFPiotr Frydrychowski
Piotr Frydrychowski
JGJustyn Gach
Justyn Gach
Z(Zuzanna Julia Wojtczak (Sidoruk)
Zuzanna Julia Wojtczak (Sidoruk)
ANAgnieszka Noszczyk-Nowak
Agnieszka Noszczyk-Nowak